US eosinophilic esophagitis market to reach $1.19 billion by 2030, forecasts GlobalData EP News Bureau Aug 25, 2025 Market growth driven by FDA-approved therapies Dupixent, Eohilia, and late-stage pipeline candidate APT-1011, according to…
